InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by WARNECKE STEVE B, Chairman & CEO. Director active across 1 companies, notably Evolutionary Genomics, INC.. In total, 3 disclosures have been recorded. The latest transaction was filed on 23 May 2022 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations3 total
€34,32666,667 shares@ €0.51490.83% mcap100.0% of flow
Common Stock
SEC:0001079973-22-000665:0·
037,500 shares0
Common Stock
SEC:0001553350-21-000447·
037,500 shares0
Common Stock
SEC:0001553350-21-000447:0·
3 of 3 declarations
About WARNECKE STEVE B
Steve B. Warnecke is the Chairman & CEO of Evolutionary Genomics, Inc. In this role, he is responsible for the strategic and operational direction of the company. Evolutionary Genomics specializes in genomic technologies. Mr. Warnecke's experience in the biotechnology sector is essential for the company's growth and innovation.
